E-ISSN 2587-0831
Original Article
Loss of Nuclear ARID-1A Expressions Is Associated with Hormone Receptor Status in Breast Cancers
1 Department of Pathology and Surgery, Tepecik Training and Research Hospital, İzmir, Turkey  
Eur J Breast Health 2019; 15: 125-129
DOI: 10.5152/ejbh.2019.4677
Key Words: Breast cancer, HER2, ARID1A, molecular subtype

Objective: Breast cancer is the most common cancer among women worldwide. Adenine thymine-rich interactive domain 1A (ARIDIA) is a tumor suppressor gene involved in chromatin remodeling and it encodes the ARIDIA protein. Recent studies have shown the loss of ARIDIA protein expression in different carcinomas may have a prognostic significance. In the present study, we aimed to evaluate the interactions between ARIDIA loss and molecular subtypes of breast carcinomas.


Materials and Methods: ARIDIA expressions were studied in 292 formalin- fixed, paraffin- embedded breast carcinoma specimens and its association with different pathological and clinical parameters was evaluated.


Results: Loss of ARIDIA expression was detected in 123 cases. There was no statistically significant association between ARID-1A expression and molecular subtype of breast carcinomas (p=0.110) or HER2 amplification (p=0.909). Contrarily, there was a significant association between ARIDIA expression and presence of estrogen (p=0.047) or progesterone receptors (p=0.023). Besides a statistically significant relationship was found between loss of ARID1A, and the presence of both in situ component (p=0.016) and lymph node metastasis (p=0.001).


Conclusion: In this study, we have demonstrated that loss of ARID1A expression positively correlates with hormone receptor status as well as tumor aggressiveness.


Cite this article as: Ünçel M, Diniz G, Aköz G, Yıldırım Ekin Z, Sayhan S, Yardım S, Salimoğlu S. Loss of Nuclear ARID-1A Expressions Is Associated with Hormone Receptor Status in Breast Cancers. Eur J Breast Health 2019; 15(2): 125-129.

Key Words
Author’s Corner
AVES | Copyright © 2019 Turkish Federation of Breast Diseases Associations | Latest Update: 29.03.2019